4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
25.34
-0.30 (-1.17%)
At close: May 17, 2024, 4:00 PM
24.72
-0.62 (-2.45%)
After-hours: May 17, 2024, 7:37 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $1.31 billion as of May 17, 2024. Its market cap has increased by 132.53% in one year.
Market Cap
1.31B
Enterprise Value
795.32M
1-Year Change
132.53%
Ranking
Category
Stock Price
$25.34
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has increased from $580.38M to $1.31B, an increase of 125.21%. That is a compound annual growth rate of 26.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 1.31B | -1.17% |
May 16, 2024 | 1.33B | 0.23% |
May 15, 2024 | 1.32B | -0.66% |
May 14, 2024 | 1.33B | 0.70% |
May 13, 2024 | 1.32B | -0.50% |
May 10, 2024 | 1.33B | 0.23% |
May 9, 2024 | 1.33B | 1.14% |
May 8, 2024 | 1.31B | -1.75% |
May 7, 2024 | 1.33B | 0.15% |
May 6, 2024 | 1.33B | 1.45% |
May 3, 2024 | 1.31B | - |
May 2, 2024 | 1.31B | 3.89% |
May 1, 2024 | 1.26B | 6.10% |
Apr 30, 2024 | 1.19B | -1.32% |
Apr 29, 2024 | 1.21B | 4.30% |
Apr 26, 2024 | 1.16B | -1.20% |
Apr 25, 2024 | 1.17B | -2.97% |
Apr 24, 2024 | 1.21B | -2.26% |
Apr 23, 2024 | 1.24B | -5.98% |
Apr 22, 2024 | 1.31B | 4.51% |
Apr 19, 2024 | 1.26B | 1.90% |
Apr 18, 2024 | 1.23B | -2.06% |
Apr 17, 2024 | 1.26B | -5.42% |
Apr 16, 2024 | 1.33B | 1.91% |
Apr 15, 2024 | 1.31B | -0.38% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cullinan Oncology | 1.33B |
Belite Bio | 1.33B |
Brookdale Senior Living | 1.33B |
AdaptHealth | 1.32B |
Vir Biotechnology | 1.31B |
BioCryst Pharmaceuticals | 1.29B |
ANI Pharmaceuticals | 1.29B |
MannKind | 1.25B |